Cargando…

P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES

Detalles Bibliográficos
Autores principales:	Manier, Salomon, Lesokhin, Alexander, Mohty, Mohamad, Niesvizky, Ruben, Maisel, Christopher, Arnulf, Bertrand, Larson, Sarah M., Nina Varshavsky-Yanovsky, Asya, Leleu, Xavier, Karlin, Lionel, Vesole, David H., Bahlis, Nizar J, Fernandez de Larrea, Carlos, Raje, Noopur, Leip, Eric, Sullivan, Sharon T., Elmeliegy, Mohamed, Viqueira, Andrea, Nooka, Ajay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431166/ http://dx.doi.org/10.1097/01.HS9.0000970384.26808.c7

Ejemplares similares